ISIN | LU1626129727 |
---|---|
Valor Number | 36991615 |
Bloomberg Global ID | |
Fund Name | SYNCHRONY (LU) SWISS ALL CAPS (CHF) A |
Fund Provider |
Banque Cantonale de Genève
Genève, Switzerland Phone: +41 58 211 21 11 E-Mail: info@bcge.ch Web: www.bcge.ch |
Fund Provider | Banque Cantonale de Genève |
Representative in Switzerland |
GERIFONDS SA Lausanne Phone: +41 21 321 32 00 |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The objective of the sub-fund is long-term capital growth through investments in shares and other securities or participation rights issued by Swiss companies included in the SPI® Index. Companies are selected based on their intrinsic quality and manager's convictions, as well as economic cycles and, to the greatest extent possible, sustainable criteria. No guarantee can be given that the investment objective of the sub-fund will be achieved. |
Peculiarities |
Current Price * | 152.34 CHF | 22.07.2025 |
---|---|---|
Previous Price * | 153.70 CHF | 21.07.2025 |
52 Week High * | 161.72 CHF | 13.02.2025 |
52 Week Low * | 133.25 CHF | 09.04.2025 |
NAV * | 152.34 CHF | 22.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 51,130,810 | |
Unit/Share Assets *** | 11,528,959 | |
Trading Information SIX |
YTD Performance | +3.72% |
31.12.2024 - 22.07.2025
31.12.2024 22.07.2025 |
---|---|---|
1 month | -0.31% |
24.06.2025 - 22.07.2025
24.06.2025 22.07.2025 |
3 months | +6.96% |
22.04.2025 - 22.07.2025
22.04.2025 22.07.2025 |
6 months | -1.58% |
22.01.2025 - 22.07.2025
22.01.2025 22.07.2025 |
1 year | -2.31% |
22.07.2024 - 22.07.2025
22.07.2024 22.07.2025 |
2 years | +5.70% |
24.07.2023 - 22.07.2025
24.07.2023 22.07.2025 |
3 years | +7.09% |
22.07.2022 - 22.07.2025
22.07.2022 22.07.2025 |
5 years | +15.12% |
22.07.2020 - 22.07.2025
22.07.2020 22.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 9.67% | |
---|---|---|
Novartis AG Registered Shares | 9.61% | |
Roche Holding AG | 9.55% | |
Zurich Insurance Group AG | 9.51% | |
Givaudan SA | 4.77% | |
Geberit AG | 4.63% | |
Sika AG | 4.62% | |
Lonza Group Ltd | 4.56% | |
ABB Ltd | 4.48% | |
Partners Group Holding AG | 4.46% | |
Last data update | 31.03.2025 |
TER | 1.57% |
---|---|
TER date | 31.12.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.57% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |